Major French nuclear technology firm specializing in reactor safety analysis, fuel qualification, and multiphysics simulation codes across 15 H2020 projects.
Framatome is a major French nuclear technology company that designs, manufactures, and services components for nuclear power plants and research reactors. Within H2020, they contribute deep engineering expertise in reactor safety analysis, nuclear fuel development (including low-enriched uranium fuels for research reactors), and advanced simulation codes for safety assessment. Their work spans the full nuclear lifecycle — from Generation IV reactor design and severe accident management to structural integrity of aging plants and qualification of new fuel systems.
Central theme across IVMR (melt retention), SAMOFAR (molten salt safety), ESFR-SMART (sodium fast reactor safety), SAMOSAFER (severe accident modeling), ELSMOR (SMR safety), and NARSIS (probabilistic safety assessment).
Major investments in LEU-FOREvER (UMo/U3Si2 fuels), EU-QUALIFY (medical isotope fuel supply, their largest single grant at EUR 3.26M), and HERACLES-CP (reactor conversion).
Coordinated CAMIVVER on CATHARE/RELAP/TRACE/APOLLO/SERPENT code improvements, and contributed modeling tools in SAMOSAFER.
Participated in INCEFA-PLUS, INCEFA-SCALE (environmental assisted fatigue), and ATLASplus (structural integrity for long-term operation).
Contributed to ESFR-SMART (sodium fast reactors), PUMMA (plutonium management for Gen-IV), and SAMOFAR (molten salt fast reactor).
NUCOBAM project explores 3D-printed nuclear components — a new manufacturing direction for the company.
In the early H2020 period (2015–2018), Framatome focused on foundational reactor safety — severe accident management for existing plants (IVMR), Gen-IV reactor validation (ESFR-SMART), probabilistic safety assessment (NARSIS), and structural integrity of aging infrastructure (ATLASplus, INCEFA-PLUS). From 2019 onward, the focus shifted markedly toward advanced simulation tools, small modular reactors (ELSMOR), and securing nuclear fuel supply chains (EU-QUALIFY). The coordination of CAMIVVER in 2020, focused on multiphysics code coupling, signals Framatome's growing ambition to lead — not just participate — in safety modeling for next-generation reactor designs.
Framatome is moving from broad safety research participation toward leadership in simulation tools and fuel supply security — positioning for the European SMR licensing wave and medical isotope production needs.
Framatome operates almost exclusively as a consortium participant (13 of 15 projects), contributing specialized industrial expertise rather than leading academic-style research. They coordinated only one project (CAMIVVER), suggesting they prefer to bring targeted engineering capability to established consortia rather than manage large multi-partner efforts. With 86 unique partners across 24 countries, they are a well-connected hub in the European nuclear research ecosystem — a reliable industrial partner that many groups want in their consortium for credibility and real-world engineering knowledge.
Framatome has collaborated with 86 distinct partners across 24 countries, making them one of the most broadly connected industrial players in European nuclear R&D. Their reach spans essentially all EU nuclear-active nations, reflecting their status as a top-tier industry partner that research consortia actively seek out.
Framatome is one of very few private companies in Europe that combines nuclear fuel manufacturing capability with advanced safety simulation expertise — most competitors have one or the other, not both. Their dual role as both a reactor component manufacturer and a safety analysis provider means they bring real operational constraints and industrial validation to research projects, not just theoretical models. For consortium builders, having Framatome on board signals industrial relevance and a credible path from research results to deployed technology.
